Market Signal Briefing

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Options traders in the Bitcoin market are now pricing in a better-than-even chance that the coin stays under $66,000 through late April — a sign of how quickly sentiment has turned since Thursday.

Fear Takes Hold In The Options Market The shift shows up clearly in one key metric. Bitcoin’s 30-day options delta skew climbed to 15% on Friday, a level that signals traders are paying a sharp premium for downside protection.

Under normal conditions, that figure sits between -6% and 6%. Based on data from derivatives platform Deribit, put options — bets that price will fall — were trading at 0.0580 BTC, or roughly $3,786, for an April 24 contract at the $66,000 strike.

That pricing implies a 50% probability of Bitcoin staying below that level by month’s end. Fear has been the dominant force in Bitcoin options since mid-January.

The broader selloff hit hard on Friday. Bitcoin dropped to $65,500, a 7.5% fall from the $71,300 it had reached just the day before. That single move wiped out more than $200 million in leveraged long positions and rendered nearly all call options worthless ahead of an $18.5 billion monthly expiry.

Bitcoin option prices for April 24. Source: Deribit Bears were in control. Put options at the $69,000 strike or above carried over $2 billion in open interest, and 95% of call options expired void.

Part of the drop, reports indicate, had little to do with price conviction. Some traders simply didn’t want to carry Bitcoin exposure into the weekend, a common pattern when geopolitical risk is elevated and US markets are about to close.

Source: Alternative.me Oil At $100 And Rising Bond Yields Squeeze Risk Assets The pressure on Bitcoin didn’t come from crypto alone. West Texas Intermediate crude oil hit $100 a barrel on Friday. The jump is tied to rising tension in the Middle East, along with projections of up to $200 billion in additional US military spending.

BTCUSD currently trading at $66,160. Chart: TradingView That combination stoked inflation fears and pushed investors toward safer positions. Five-year US Treasury yields reached 4%, up from 3.70% just three weeks earlier — a fast move by bond market standards. The S&P 500 fell to its lowest point since September 2025.

Where Bitcoin Might Be Headed Meanwhile, Bitcoin has underperformed the S&P 500 by 20% so far this year. That gap is wider than the broader macro environment alone can explain.

For now, the options market has its answer on where Bitcoin is headed this April — and it isn’t higher. With macro pressure building, policy tailwinds fading, and traders reluctant to hold through the weekend, the path of least resistance points downward.

Whether Bitcoin holds $66,000 or breaks below it may depend less on the coin itself and more on what happens in Washington and the Middle East before the month runs out.

Featured image from Pexels, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Sign Up for Our Newsletter! For updates and exclusive offers enter your email.

Christian, a journalist and editor with leadership roles in Philippine and Canadian media, is fueled by his love for writing and cryptocurrency. Off-screen, he's a cook and cinephile who's constantly intrigued by the size of the universe.

TLDR: Bitcoin has outperformed inflation 97% of the time, far exceeding gold’s 56% performance. Geopolitical tensions and rising oil prices may drive investor interest toward Bitcoin. Ethereum’s adoption by Wall Street and AI systems could increase its long-term value. Bitmine’s Ethereum holdings, staking, and venture investments position it for institutional growth. Bitmine CEO Tom Lee emphasized Bitcoin’s performance against inflation at the Futu Investment Exhibition. He stated that since its creation, Bitcoin has outperformed inflation 97% of the time, compared to gold’s 56%.

Lee highlighted that this consistency makes Bitcoin a reliable store of value, attracting institutional attention, especially as the crypto winter shows signs of ending.

Bitcoin’s Inflation Resilience and Market Context According to Lee, macroeconomic conditions are shaping investor behavior. Ongoing geopolitical tensions and elevated oil prices may slow global growth while benefiting the U.S. economy.

This environment encourages capital allocation to assets correlated with technology and growth, including Bitcoin.

Bitcoin’s long-term track record as an inflation hedge reinforces its appeal. Lee noted that gold, historically seen as a safe haven, has underperformed in comparison, creating a shift in institutional preferences. During the event, Tom Lee highlighted, “Bitcoin outperforms traditional inflation hedges over decades.”

Ethereum’s performance was also discussed, showing patterns similar to past market bottoms in the S&P 500. Analysis of Ethereum’s realized price suggests undervaluation relative to historical recovery points. Lee pointed out that these conditions may support renewed investor interest in crypto markets overall.

Investor behavior is responding to these signals. Reduced sell-side pressure, growing on-chain activity, and improved market sentiment suggest digital assets, particularly Bitcoin, are positioned for potential recovery and broader adoption.

Ethereum Prospects and Bitmine’s Strategy Lee outlined Ethereum’s emerging role in traditional finance. Wall Street adoption is a primary factor driving future value.

Tokenization allows continuous trading, increased collateral mobility, and more efficient financial processes. Ethereum is viewed as the standard platform enabling these transformations.

AI developments also strengthen Ethereum’s potential. Agentic systems require decentralized identities and instant settlement, which blockchain networks can provide.

Ethereum’s smart accounts are being adapted to support autonomous applications. A tweet during the discussion noted, “Ethereum is preparing for AI and decentralized financial integration.”

Bitmine itself is strategically positioned to leverage these trends. The company maintains significant Ethereum holdings, high trading volumes, and pursues yield-generating strategies. Its Maven initiative focuses on large-scale staking to increase institutional returns.

Investments in ventures like Beast Industries and Orbs, which link to projects such as Worldcoin, further expand Bitmine’s market reach.

Ethereum price targets range from $12,000 to over $62,000, potentially translating to Bitmine share prices between $500 and $1,500, reinforcing the company’s growth prospects.

TLDR: Goliath mainnet is now live and fully integrated into the Onyx App for real-world DeFi use. XCN liquid staking auto-accrues rewards, removing manual claims and boosting capital efficiency. The native bridge enables seamless XCN transfers between Ethereum ERC-20 and Goliath networks. Goliath runs on aBFT consensus, supporting payments, governance, healthcare, and supply chain use cases. Goliath mainnet is now live and fully integrated into the Onyx App. The launch marks a major step forward for the Onyx ecosystem. Users can now access bridging, liquid staking, and swapping at app.onyx.org.

The XCN token retains its native Ethereum ERC-20 support alongside the new mainnet. This release brings production-ready consensus, staking, and cross-chain interoperability into real-world use for the first time.

Liquid Staking and Swapping Now Available Across the Network The Onyx Protocol team announced liquid staking integration directly within the updated Onyx App. Users can stake XCN and maintain liquidity at the same time.

Rewards accumulate automatically through a cumulative index, removing the need for manual claims. When users unstake, they receive their XCN and accrued rewards in one transaction.

The swap feature currently supports XCN, ETH, and USDC on the mainnet. Swaps are accessible when the new network is selected within the app.

This adds capital efficiency to the staking model already in place. The combined tools position the platform as a functional DeFi infrastructure layer.

Onyx Protocol confirmed the development on social media, stating that users can now access Goliath bridging, XCN liquid staking, and swaps at app.onyx.org.

The team also confirmed that XCN will remain the default Ethereum ERC-20 token alongside the new chain. This dual structure allows users to operate across both networks without disruption.

The staking model is built around modern DeFi standards. Capital efficiency remains central to the overall infrastructure design.

Native Bridge Enables XCN Transfers Between Ethereum and Goliath The native bridge now allows XCN transfers between Ethereum and the mainnet. Users can move assets across both chains through the Onyx App directly.

The bridge supports the ERC-20 standard on one end and the native asset on the other. This setup makes cross-chain activity more accessible for everyday users.

The network operates on asynchronous Byzantine Fault Tolerance, or aBFT, consensus. This architecture delivers high throughput, deterministic finality, and fair transaction ordering.

Tamper-proof execution is also built into the core design. These properties support use cases such as cross-border payments, healthcare audits, and supply chain verification.

The team outlined the next development phase following the mainnet launch. Plans include expanding validator participation and enhancing cross-chain capabilities further.

Developer ecosystem growth and real-world application scaling are also on the roadmap. The project aims to serve mission-critical industries across multiple sectors.

With the network now operational, the Onyx ecosystem moves into a new phase of growth. Staking, bridging, and swapping are now consolidated within one platform.

Further updates are expected as the validator set expands. The XCN token continues to anchor the ecosystem across both Ethereum and Goliath.

Solana (SOL) hovered around the $83 level on Friday ET, navigating a broader risk-off tape while pointing to strengthening network fundamentals through a major protocol upgrade and a rebound in decentralized exchange activity. The price action underscores a familiar tension in crypto markets: short-term macro-driven volatility versus longer-term ecosystem growth.

SOL was last changing hands near $83.16, down about 1.8% over the past 24 hours, after crude oil surged to roughly $110 per barrel and pressured major cryptocurrencies including Bitcoin (BTC) and Ethereum (ETH). Analysts tracking near-term technical levels have marked $80–$85 as a critical support zone, with $92 framed as the first meaningful resistance. Momentum indicators such as the relative strength index (RSI) sat in broadly neutral territory near 54, suggesting neither buyers nor sellers have decisive control.

Still, positioning has become fragile. Data cited by market watchers showed roughly $14 million in long liquidations clustered during the latest pullback, amplifying downside pressure and highlighting the market’s sensitivity to leverage. The next directional move may hinge on whether SOL can defend the low-$80s; a break below support could open a path toward the $70 area, while reclaiming the $95–$100 band would be read by many as a stronger shift back toward bullish conditions.

Behind the volatile tape, Solana’s core narrative has increasingly centered on performance upgrades aimed at institutional-grade throughput. The Solana Foundation has been rolling out the ‘Alpenglow’ (SIMD-0326) upgrade in phases, targeting a dramatic reduction in transaction finality time—from about 12 seconds to under 150 milliseconds. The upgrade introduces off-chain voting mechanics and a ticket-based system designed to strengthen infrastructure for ‘institutional demand’ and high-frequency trading, where latency and predictability can materially affect execution quality.

Alpenglow is also being positioned as part of a broader 2026 roadmap that emphasizes scaling headroom and validator performance. Proposed changes include SIMD-0286, which would increase compute units per block from 60 million to 100 million—an expansion of roughly 66%—alongside continued efforts around the Firedancer validator client, a key initiative intended to improve resilience and performance through implementation diversity. A separate upgrade dubbed ‘Glamsterdam,’ expected later this year, is targeting around 10,000 transactions per second (TPS). The roadmap also includes plans to add enterprise privacy tooling and more customizable execution environments in the second half of 2026.

On the demand side, Solana reclaimed the top spot in March DEX volume, recording about $49 billion and outpacing Ethereum by approximately 32%, according to figures referenced in the report. Activity was concentrated in major Solana-native venues such as Orca and Raydium, as liquidity provision improved and user engagement rose across DeFi, NFTs, and meme-coin trading. Market participants often treat sustained on-chain activity during price drawdowns as a sign of underlying network health, even if token prices remain correlated with macro sentiment.

Institutional signals also appeared to be building. Asset manager 21Shares noted a dividend distribution related to its Solana exchange-traded product, 21Shares Solana ETF (TSOL), a development some observers interpreted as another incremental step in broadening institutional participation alongside existing Ethereum-linked products. At the same time, the liquidation event near the $100 resistance area served as a reminder that leverage can quickly unwind when prices struggle at key technical thresholds.

Macro conditions remain a central variable. As a high-beta asset, SOL has tended to magnify broader shifts in risk appetite, and the combination of rising energy prices and persistent global liquidity tightening has weighed on sentiment across crypto and other risk markets. Trading activity has also remained heavily concentrated on centralized exchanges: SOL’s 24-hour trading volume was estimated around $3.2 billion, with roughly 99.9% attributed to CEX venues—an indication that larger traders and institutional-sized flows continue to dominate price discovery.

For now, traders are watching two overlapping storylines: whether SOL can stabilize above the low-$80s amid macro uncertainty, and whether the completion milestones for ‘Alpenglow’—along with the timing of ‘Glamsterdam’—translate into a durable catalyst for renewed momentum. The market’s verdict may ultimately depend on how quickly technical progress converts into sustained user growth and deeper ‘liquidity inflow’ across Solana’s on-chain economy.

Article Summary by TokenPost.ai

🔎 Market Interpretation

Price vs. macro backdrop: SOL traded near $83 (≈-1.8% 24h) as a broader risk-off move (oil near $110) weighed on BTC/ETH and spilled into high-beta altcoins.

Key technical map: Traders are focused on $80–$85 as a pivotal support band and $92 as first resistance; a loss of support risks a move toward $70, while reclaiming $95–$100 would signal stronger bullish re-acceleration.

Momentum is neutral, but positioning is fragile: RSI around 54 implies no clear trend control, yet roughly $14M in long liquidations shows leverage sensitivity—small price drops can cascade.

Fundamentals diverge from tape: While macro-driven volatility dominates near-term pricing, the article highlights strengthening network fundamentals from protocol performance upgrades and a rebound in on-chain DEX activity.

Where price discovery happens: SOL’s $3.2B estimated 24h volume was ~99.9% on CEXs, suggesting large traders/institutions still drive short-term price action more than on-chain venues.

💡 Strategic Points

Support defense is the tactical trigger: Many short-term strategies hinge on whether SOL holds the low-$80s; breakdown scenarios point to deleveraging and momentum selling, while consolidation above support can reset risk.

Watch the upgrade cadence as a sentiment catalyst: The phased rollout of Alpenglow (SIMD-0326) targets a reduction in finality from ~12s to <150ms, which—if delivered—could strengthen Solana’s pitch for latency-sensitive flows (HFT, institutional execution).

Roadmap implies scaling headroom: Proposed SIMD-0286 would raise compute units per block from 60M to 100M (~66% increase), while Firedancer adds validator-client diversity aimed at resilience and performance.

Near-term throughput narrative: The planned “Glamsterdam” upgrade later this year targets roughly 10,000 TPS, reinforcing the chain’s performance-led narrative.

On-chain demand as a confirmation signal: Solana leading March DEX volume (~$49B) and surpassing Ethereum by ~32% may be read as “usage resilience” during drawdowns—often a constructive medium-term indicator if sustained.

Institutional breadcrumb: 21Shares’ dividend distribution tied to TSOL is presented as incremental institutional participation, but the article cautions that leverage can still unwind quickly near resistance (notably around $100).

Execution insight for participants: With CEXs dominating volume, short-term traders may prioritize liquidity/market-structure signals (liquidation clusters, key levels), while long-term holders may focus on milestone delivery and sustained DeFi/NFT user growth.

📘 Glossary

Risk-off: A market regime where investors reduce exposure to volatile assets (e.g., crypto) in favor of safer holdings.

Support / Resistance: Price zones where buying (support) or selling (resistance) historically concentrates, often shaping near-term trading decisions.

RSI (Relative Strength Index): A momentum indicator (0–100) used to gauge overbought/oversold conditions; ~50 is typically considered neutral.

Liquidation: Forced closing of leveraged positions by an exchange when collateral is insufficient, which can accelerate price swings.

DEX (Decentralized Exchange): An on-chain trading venue using smart contracts rather than centralized order books/custodians.

CEX (Centralized Exchange): A custodial exchange where most crypto spot/perp volume and short-term price discovery often occurs.

Finality: The time until a blockchain transaction is considered irreversible with high confidence.

SIMD: “Solana Improvement Document,” a proposal format for network upgrades (e.g., SIMD-0326, SIMD-0286).

Compute units per block: A resource budget determining how much computation can be included in each block; higher limits can increase throughput.

Validator client (Firedancer): Alternative software for running validators; multiple clients can improve network robustness and performance.

TPS (Transactions per second): A throughput metric indicating how many transactions a network can process each second.

Institutional-grade throughput: Performance/reliability characteristics (latency, predictability, capacity) expected by professional trading and enterprise users.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apollo Global Management, Inc. (NYSE: APO) between May 10, 2021 and February 21, 2026, both dates inclusive (the "Class Period"), of the important May 1, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Apollo Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Apollo Global class action, go to https://rosenlegal.com/submit-form/?case_id=1323 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 1, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) defendants Marc Rowan and Leon Black, among other leadership figures at Apollo Global, frequently communicated with Jeffrey Epstein in the 2010s regarding Apollo Global's business; (2) as a result, Apollo Global's assertion that Apollo Global had never done business with Jeffrey Epstein was untrue; (3) because of the entanglement between Apollo Global's leaders and Jeffrey Epstein, the harm to Apollo Global's reputation was more than a mere possibility; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Apollo Global class action, go to https://rosenlegal.com/submit-form/?case_id=1323 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290276

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

New York, New York--(Newsfile Corp. - March 28, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aquestive Therapeutics, Inc. (NASDAQ: AQST) between June 16, 2025 and January 8, 2026, both dates inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Aquestive securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Aquestive class action, go to https://rosenlegal.com/submit-form/?case_id=55756 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 4, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose the true state of Aquestive's New Drug Application ("NDA") for Anaphylm; pertinently, Aquestive concealed or otherwise minimized the significance of the human factors involved in the use and deployment of its sublingual film, such as packaging, use, administration, and labeling. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Aquestive class action, go to https://rosenlegal.com/submit-form/?case_id=55756 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290278

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Duolingo To Contact Him Directly To Discuss Their Options

If you suffered significant losses in Duolingo stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Duolingo, Inc. ("Duolingo" or the "Company") (NASDAQ: DUOL).

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Duolingo Inc. shares tumbled as much as 22% on February 27th after the company said its drive to gain subscribers would mean slower earnings growth and narrower profit margins in the short term. The language-learning app company said it would step up investment in artificial intelligence and sacrifice some degree of monetization in order to accelerate user growth and engagement, with the goal of doubling the current number of daily active users to 100 million in 2028. "The short-term implication is that this year will see slower bookings growth and lower profitability," Chief Executive Officer Luis von Ahn said in a letter to shareholders. Daily active users grew the slowest in four years, rising 30% in the quarter from a year ago. The company expects first-quarter adjusted Ebitda of $73.6 million, trailing analyst estimates of $84 million.

To learn more about the Duolingo investigation, go to www.faruqilaw.com/DUOL or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Also from this source

A

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alight To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Alight between November 12, 2024 and February 18, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Alight, Inc. ("Alight" or the "Company") (NYSE: ALIT) and reminds investors of the May 15, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Alight's growth potential and financial stability; notably, that the Company was not truly equipped to execute on its claimed potential and could not maintain its promised dividend as a result. Rather, Alight would require significantly higher compensation and incentive expenses to achieve the projections put forth by management. Throughout the class period, Defendants announced disappointing results, reduced projections, and multiple goodwill impairments all while remaining confident in their ability to execute, drive growth, and continue to provide a dividend to their shareholders.

On February 19, 2026, Alight reported a Q4 earnings miss, disclosed customer renewal rates significantly below its previously provided targets, and projected further revenue declines into early 2026. The Company also eliminated its quarterly dividend, declined to provide full-year guidance, and recorded a substantial, multibillion dollar goodwill impairment that reduced the value of its balance sheet.

On this news, Alight's stock price fell $0.50 per share, or 38.17%, to close at $0.81 per share on February 19, 2026.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Alight's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Alight class action, go to www.faruqilaw.com/ALIT or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Ocean Power Technologies Inc (NYSE-A:OPTT) CEO Philipp Stratmann talked with Proactive about the company’s first shipment under its $6.5 million contract with the US Department of Homeland Security, marking a major operational milestone.

Proactive: Welcome back inside our Proactive newsroom. Joining me now is Philipp Stratmann, CEO of Ocean Power Technologies. Philipp, it’s always great to see you. How are you today?

Philipp Stratmann: Doing well, thanks for having me on again.

You’ve announced news about the first shipment of your PowerBuoy system under contract with the US Department of Homeland Security. This is part of a $6.5 million contract we’ve discussed before. This first shipment is a big milestone.

Yes, it’s a major milestone. Earlier in January we announced the contract award, and just a couple of weeks ago we confirmed the full deployment contract. Now we’re already shipping the first system, with the second ready for shipment and others to follow soon.

I think it shows that we generate demand, convert that into backlog, and then quickly ship and convert it into revenue. It’s exciting to see these systems moving out and being used operationally as designed.

It also highlights the importance of ocean security, especially given recent global events. Are you seeing increased inbound interest?

Absolutely. We’ve been saying for years that ocean security is national security. Current global events are making people realize how dependent everyday life is on secure oceans where shipping can flow freely.

To achieve that, you need visibility into what’s happening at sea. Our systems are designed for that. Whether in California, the Middle East, or elsewhere, this is part of solving the broader challenge of identifying and addressing threats that impact global shipping.

If there is insufficient awareness of what’s happening in the ocean, it can materially impact commercial shipping—not just military operations.

Do you actively manage inventory and fleet size to anticipate demand?

Absolutely. It’s a balance between having the right level of inventory and fleet size available while not tying up unnecessary working capital.

We’re continuing to build out buoy inventory and expand our USV fleet so we can deploy quickly for customers. As you’ve seen, we secured the order in early January and within 10 to 12 weeks we’re already shipping systems for deployment.

It sounds like a busy 2026 ahead. Philipp, great to catch up and congratulations on the milestone.

Thank you. Good to be on.

Quotes have been lightly edited for style and clarity

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Snowflake To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Snowflake between June 27, 2023 and February 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Snowflake Inc. ("Snowflake" or the "Company") (NYSE: SNOW) and reminds investors of the April 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) product efficiency gains, Iceberg Tables and tiered storage pricing were expected to have a material negative impact on consumption and revenues, and (2) as a result, Defendants' positive statements about consumption patterns, revenues, and demand for Snowflake products lacked a reasonable basis.

On February 28, 2024, Snowflake shocked investors when, after the market closed, the Company issued a press release and filed a report with the SEC on Form 8-K that disclosed its financial results for the quarter ended January 31, 2024 and full fiscal year 2024. On that same day, during a conference call with investors and analysts after the disclosure of Snowflake's financial results, Defendant Scarpelli stated that they were forecasting increased revenue headwinds associated with product efficiency gains, tiered storage pricing and the expectation that some of their customers will leverage Iceberg Tables for their storage. On that same day, Snowflake also issued a press release and filed a report with the SEC on Form 8-K that disclosed that effective February 27, 2024, Frank Slootman retired as Chief Executive Officer of Snowflake Inc.

On this news, the price of Snowflake's Class A common stock declined $41.72, or 18.14%, from a closing price of $230.00 per share on February 28, 2024, to close at $188.28 per share on February 29, 2024.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Snowflake's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Snowflake class action, go to www.faruqilaw.com/SNOW or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BlackRock TCP To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in BlackRock TCP between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlackRock TCP Capital Corp. ("BlackRock TCP" or the "Company") (NASDAQ: TCPC) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company's investments were not being timely and/or appropriately valued; (2) the Company's efforts at portfolio restructuring were not effectively resolving challenged credits or improving the quality of the portfolio; (3) as a result, the Company's unrealized losses were understated; (4) as a result, the Company's NAV was overstated; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On February 27, 2025, before the market opened, the Company issued a press release announcing financial results for the fourth quarter and year ended December 31, 2024. The press release disclosed that the Company's portfolio had significantly weakened during the 2024 fiscal year. Specifically, the press release revealed the number of portfolio companies on non-accrual status had more than doubled, and as a result, debt investments on non-accrual status at cost increased by 289% (from 3.7% to 14.4% of the portfolio). Moreover, the press release revealed that the Company's net asset value ("NAV") had fallen 22.44% year over year to $9.23 per share. Total losses, both realized and unrealized, were revealed to have ballooned to $194,895,042 for the fiscal year, a 186% increase year over year, in large part due to a newly added $72.3 million net unrealized loss within the fourth quarter. Despite this, the press release alleged the NAV of the Company was accurate at $9.23 per share, and that "the vast majority of [the Company's] portfolio continued to perform well," and the Company was "working closely with [its] borrowers and sponsors to resolve the portfolio issues."

On this news, the Company's stock price fell $0.90, or 9.64%, to close at $8.44 per share on February 27, 2025, on unusually heavy trading volume.

On January 23, 2026, after market hours, BlackRock TCP disclosed certain fourth quarter and full year 2025 financial results, including that the Company's NAV per share as of December 31, 2025 was in fact in the range of $7.05 to $7.09, 19% less than reported the prior quarter and 23.4% less than reported the prior year.

On this news, BlackRock TCP's stock price fell $0.76, or 12.97%, to close at $5.10 per share on January 26, 2026, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding BlackRock TCP's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the BlackRock TCP class action, go to www.faruqilaw.com/TCPC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

197 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

5.53K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Eos Energy To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Eos Energy between November 5, 2025 and February 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eos Energy Enterprises, Inc. ("Eos Energy" or the "Company") (NASDAQ: EOSE) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company was unable to achieve the ramp in production and capacity utilization required to achieve its previously set guidance; (2) the Company's battery line downtime was running well above industry norms, the design intent of the line, and internal forecasts; (3) the Company was experiencing delays in the ability for its automated bipolar production to hit quality targets; (4) the Company's inadequate systems and processes prevented it from ensuring reasonably accurate guidance and that its public disclosures were timely, accurate, and complete; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On February 26, 2026, Eos Energy announced fourth quarter and full year 2025 results, reporting, among other things, full year 2025 revenue of $114.2 million, falling far short of the Company's previously issued guidance of $150 to $160 million. Management attributed these results to, in part, that "battery line downtime ran well above industry norms" and "the ability for the automated bipolar production to hit quality targets took longer than expected." The Company further disclosed it had "uncovered inefficiencies that result in longer end-to-end production times."

On this news, Eos Energy's stock price fell $4.39, or 39.4%, to close at $6.74 per share on February 26, 2026, thereby injuring investors.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Eos Energy's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Eos Energy Enterprises class action, go to www.faruqilaw.com/EOSE or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Did you buy GEMI Class A common stock and/or securities between September 12, 2025, and February 17, 2026?

Affected GEMI Investor Summary

Who: Gemini Space Station, Inc. (NASDAQ: GEMI) What: Securities fraud class action lawsuit filed Class Period: September 12, 2025 through February 17, 2026 Deadline to Seek Lead Plaintiff Status: May 18, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's registration statement and prospectus issued in connection with its IPO. Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options , /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) on behalf of those who purchased or acquired: 1) Gemini Class A common stock pursuant and/or traceable to the company's registration statement and prospectus issued in connection with Gemini's IPO conducted on or about September 12, 2025; and/or 2) Gemini securities between September 12, 2025 and February 17, 2026, both dates inclusive. The lawsuit is filed in the United States District Court for the Southern District of New York and is captioned Methvin v. Gemini Space Station, Inc., et al, Case No. 1:26-cv-02261 (S.D.N.Y.). Investors have until May 18, 2026, to file for lead plaintiff status. 

CONTACT KTMC TO DISCUSS YOUR LEGAL RIGHTS:
If you purchased or acquired Gemini Class A common stock and/or Gemini securities and have lost money on your investment, you are encouraged to contact KTMC attorney Jonathan Naji, Esq. at:

(484) 270-1453 [email protected] https://www.ktmc.com/gemi-gemini-space-station-inc-class-action-lawsuit?utm_source=PR_Newswire&utm_medium=pressrelease&utm_campaign=gemi&mktm=PR There is no cost or obligation to speak with an attorney.

GEMINI SPACE STATION, INC. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:
The complaint alleges that, in the Offering Documents (the company's registration statement and prospectus issued in connection with Gemini's IPO) and throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company's business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) Gemini had overstated the viability of its core business as a crypto platform; (2) Gemini had overstated the company's commitment to and/or the viability of growing its business through expanding its international operations; (3) accordingly, Gemini's post-IPO financial and business prospects were overstated; (4) all of the foregoing raised a non-speculative risk that Gemini was poised for an expensive and disruptive restructuring; and (5) as a result, Defendants' positive statements about the company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Why did Gemini's Stock Drop?
On February 5, 2026, Gemini announced a corporate pivot to "Gemini 2.0", describing three dramatic changes to Gemini's operations: (1) Gemini's prediction market would be "more front and center in our experience"; (2) Gemini would reduce its workforce by 25%; and (3) Gemini would exit the United Kingdom, European Union, and Australian markets. On this news, Gemini's Class A common stock price fell $0.64 per share, or 8.72%, to close at $6.70 per share on February 5, 2026.

Then, on February 17, 2026, Gemini announced the departure of its Chief Operating Officer, Chief Financial Officer, and its Chief Legal Officer. Gemini also released preliminary unaudited estimates of its full year 2025 financial results, which revealed an approximate 40% increase in the company's operating expenses. On this news, Gemini's Class A common stock price fell $0.97 per share, or 12.9%, to close at $6.585 per share on February 17, 2026.

At the time the complaint was filed, Gemini's Class A common stock traded at $5.96 per share, a 78.7% decline from the company's $28.00 per share IPO price.

WHAT GEMI INVESTORS CAN DO NOW:

File to be lead plaintiff by May 18, 2026. Contact KTMC for a free case evaluation. All representation is on a contingency fee basis, there is no cost to you. Retain counsel of choice or take no action. THE LEAD PLAINTIFF PROCESS FOR GEMINI SPACE STATON, INC. INVESTORS:
Gemini investors may, no later than May 18, 2026, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.

Kessler Topaz Meltzer & Check, LLP encourages Gemini investors to contact the firm for more information.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP (KTMC):
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal's Plaintiff's Hot List and Trailblazers in Plaintiffs' Law, BTI Consulting Group's Honor Roll of Most Feared Law Firms, The Legal Intelligencer's Class Action Firm of the Year, Lawdragon's Leading Plaintiff Financial Lawyers, and Law360's Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com. The complaint in this matter was not filed by KTMC.

CONTACT:
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

SOURCE Kessler Topaz Meltzer & Check, LLP

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Soleno between March 26, 2025 and November 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

James (Josh) Wilson, Faruqi & Faruqi Senior Partner (PRNewsfoto/Faruqi & Faruqi, LLP) Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Soleno Phase 3 clinical trial program for DCCR had systematically downplayed, misrepresented, and/or concealed significant evidence of safety concerns potentially related to the administration of DCCR, including issues related to excess fluid retention in clinical trial participants; (2) as a result, the administration of DCCR to treat hyperphagia in individuals with PWS posed materially greater safety risks than disclosed by Soleno or its executives; and (3) consequently, DCCR had materially lower commercial viability and undisclosed risks related to the likelihood of significant and widespread adverse events after its commercial launch, including risks related to patient discontinuation rates, lower patient adoption, prescriber reluctance, adverse regulatory action, and potential reputational and legal fallout.

On August 15, 2025, Scorpion Capital LLC published a report critical of Soleno Therapeutics, Inc., its drug candidate DCCR, and the company's Phase 3 clinical trial program. The report alleged significant concerns regarding the drug's safety, efficacy, and clinical trial data. On this news, the price of Soleno common stock declined from a high of more than $77 per share on August 14, 2025 to close at approximately $68 per share on August 18, 2025, a decline of nearly 12% over two trading days.

Subsequently, on September 10, 2025, Soleno filed a Form 8-K with the U.S. Securities and Exchange Commission disclosing that a patient had died after taking DCCR.On this news, the price of Soleno common stock declined from more than $70 per share on September 9, 2025 to close at approximately $57 per share on September 11, 2025, a decline of approximately 19% over two trading days.

Lastly, on November 4, 2025, Soleno reported its financial results for the third quarter ended September 30, 2025, revealing that the earlier Scorpion Capital report had disrupted the launch trajectory of DCCR and raised concerns within the Prader-Willi syndrome community, resulting in fewer patient start forms and increased discontinuations. On this news, the price of Soleno common stock declined from nearly $64 per share on November 4, 2025 to close at approximately $47 per share on November 5, 2025, a one-day decline of approximately 27%.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. 

Faruqi & Faruqi, LLP also encourages anyone with information regarding Soleno's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Soleno Therapeutics class action, go to www.faruqilaw.com/SLNO or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE Faruqi & Faruqi, LLP

Walker & Dunlop (WD 4.07%) has been a victim of the higher interest rates over the past few years, which have resulted in an extremely slow commercial real estate market. However, this well-run company now offers a 6% dividend yield and just gave some pretty ambitious five-year projections. Is the stock worth buying now?

*Stock prices used were the morning prices of March 25, 2026. The video was published on March 28, 2026.

Matt Frankel, CFP has positions in Walker & Dunlop. The Motley Fool has positions in and recommends Walker & Dunlop. The Motley Fool has a disclosure policy.

Matthew Frankel is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

HomeStock IdeasLong IdeasIndustrial 

SummaryBlackSky reported improved 4Q25 profitability, a 32% backlog increase to $345 million, and strong Gen-3-driven commercial traction, despite modest revenue growth.BKSY’s investment case centers on scaling Gen-3 deployments, converting backlog into high-margin, recurring AI and imagery subscriptions, and achieving operating leverage.Valuation remains premium, with EV/sales at 8.6x forward, reflecting expectations for accelerated growth and margin expansion; execution risk is high if growth or capital discipline falters.2026 performance will hinge on backlog conversion, consistent subscription growth, margin expansion, and controlling capital intensity as Gen-3 capacity comes online. SW Photography/DigitalVision via Getty Images

Thesis BlackSky (BKSY) managed to report a 4Q25 GAAP EPS of -$0.02, a figure that beat expectations by $0.16. Revenue, on the other hand, came in at $35 million, up about 16% since last year but missing estimates by about $2.1 million. The

1.14K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

HomeIndustriesComputers/ElectronicsTech StocksTech StocksShares of Veeco and Axcelis have lagged their larger semiconductor-equipment peers, making them potentially compelling opportunities for investorsPublished: March 28, 2026 at 9:00 a.m. ET

Shares of chip-equipment makers have been hot in recent months, with the companies seen as somewhat agnostic plays on the booming budgets being allocated to artificial-intelligence buildouts.

In the process, some of the most high-profile semiconductor-equipment stocks have gotten quite expensive. But investors who still want to get in on this theme at more reasonable valuation levels might consider shares of two smaller players whose multiples aren’t yet so frothy.

There were plenty of reasons to be bullish on nuclear energy prior to the events across the Middle East over the past month.

From the power needs of artificial intelligence (AI) to a general push for carbon-free energy production, nuclear technology was already seeing a renaissance.

Then, because of the escalating war between Iran, the United States, and Israel, Iran closed the Strait of Hormuz, through which about one-fifth of all global oil and gas moves.

The effects of the closure have been most heavily felt in Asia, but oil and gas prices the world over are on the rise.

I would not be surprised if many countries pivoted even faster toward nuclear energy to achieve a greater degree of energy independence.

Image source: Getty Images.

Per the World Nuclear Association, there are 75 nuclear reactors under construction around the world right now with another 120 planned.

Many countries have plans to expand their nuclear energy capacity over the next couple of decades, and the U.S. has one of the most ambitious goals. The Department of Energy wants to triple America's nuclear production by the middle of the century.

And nuclear energy producers like NextEra Energy (NEE +0.26%) will be one of the best ways to play the nuclear renaissance in 2026 and beyond.

The future of energy production Based in Juno Beach, Florida, NextEra energy is one of America's major nuclear operators with its seven reactors across four plants with another one on the way in 2029 (more on that shortly), the company generates 6 gigawatts of nuclear power.

The company is also engaged in solar, wind, and natural gas power generation. But the real opportunity here is nuclear, as that's the one that seems to have the most government and corporate interest behind it.

Today's Change

(

0.26

%) $

0.24

Current Price

$

91.40

That's best demonstrated by NextEra Energy's partnership with Google's parent company Alphabet.

The nuclear plant NextEra is working to bring on line in 2029 is actually the company resuscitating Iowa's decommissioned Duane Arnold Energy Center.

Per the partnership, Google will buy electricity from the Duane Arnold plant for the next 25 years to power its data centers in the area. The agreement will also see NextEra and Google explore deployment of additional nuclear plants across the United States.

It takes a long time to build a nuclear power plant. According to the U.S. Energy Information Administration (EIA), it takes about five years on average to build a new plant.

That makes nuclear power a prime dividend investment opportunity. NextEra pays a dividend that yields 2.54% at present, and it has raised that dividend for 32 years in a row.

And with the company's current payout ratio sitting at a high but still fairly comfortable 68.67% right now, it should not have much trouble continuing to pay and raise that dividend. The company also knows how to get that ratio lower while continuing its dividend increases; it had a 94.59% payout ratio back in 2020.

Aside from its dividend indicating its financial health, NextEra maintains a net profit margin of 19.45% and for 2025, the company saw its adjusted earnings per share (EPS) grow 12% on revenue growth of 13%.

This stock is worth a look for a long-term dividend play on the nuclear renaissance, a trend I expect will accelerate in the wake of increased geopolitical tensions in the Middle East.

HomeDividends AnalysisDividend IdeasEnergy Analysis

SummaryEnterprise Products Partners (EPD) offers a sustainable, tax-advantaged 5.63% yield, underpinned by stable cash flows and a resilient distribution history.EPD's growth is driven by its leading position in natural gas liquids infrastructure, with $4.8 billion in capital projects focused on expanding capacity in high-demand regions.Distributable cash flow coverage stands at 1.66x, ensuring strong distribution sustainability even after recent increases.Despite recent unit price appreciation, EPD remains attractively valued versus C-corp peers, offering higher yields and superior tax efficiency for income-focused investors.This idea was discussed in more depth with members of my private investing community, Energy Profits in Dividends. Learn More » StevanZZ/iStock via Getty Images

Enterprise Products Partners L.P. (EPD) is a midstream master limited partnership that owns and operates a network of crude oil, natural gas, natural gas liquids, and refined products transportation infrastructure that covers much of the continental United

16.08K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MPLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

This article was originally published to Energy Profits in Dividends following the market close on March 27, 2026. Subscribers to the service have had since that time to act on it.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

14.42K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of KBDC either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

, /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Vital Farms, Inc. (NASDAQ: VITL) between May 8, 2025 and February 26, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 26, 2026 in the securities class action first filed by the Firm.

So what: If you purchased Vital Farms securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Vital Farms class action, go to https://rosenlegal.com/submit-form/?case_id=54670 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 26, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Vital Farms downplayed the risks of delay associated with the roll out of its new enterprise resource planning ("ERP") system as merely a hypothetical; (2) When the ERP roll out caused delays, Vital Farms downplayed the impact of the delay; (3) In truth, the delays caused Vital Farms to miss its full year 2025 earnings guidance and earnings per share consensus; and (4) as  a result, defendants' statements about Vital Farms' business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.  

To join the Vital Farms class action, go to https://rosenlegal.com/submit-form/?case_id=54670 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY  10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

On March 11, 2026, LeMaitre Vascular (LMAT 3.56%) Senior Vice President, Operations, Trent G Kamke, reported the exercise and immediate sale of 2,625 shares of common stock for total proceeds of approximately $285,000, according to this SEC Form 4 filing.

Transaction summaryMetricValueContextShares sold (direct)2,625Open-market shares sold (code 'S') in this filingTransaction value$284,812.50Based on SEC Form 4 weighted average purchase price ($108.50)Post-transaction shares (direct)6,677Directly held shares after transaction completionPost-transaction value (direct ownership)~$722,000Based on March 11, 2026 market closeTransaction value based on SEC Form 4 weighted average purchase price ($108.50); post-transaction value based on March 11, 2026, market close.

Key questionsWhat was the structure and rationale for the transaction?
The trade reflects an exercise of 2,625 vested options immediately followed by a direct sale of the common shares, a common mechanism for executives to monetize equity awards while maintaining compliance with company trading policies.How did this transaction impact Kamke's ownership stake?
Direct common stock holdings decreased from approximately 9,000 shares to 6,677 shares, marking a 28.22% reduction in direct equity exposure; no indirect holdings were involved or remain post-transaction.How does the trade fit within Kamke's recent activity?
This transaction matches the recent period's median sell size (2,625 shares) and percentage of holdings sold per trade (28.22%), indicating consistency in liquidation cadence as available direct holdings have declined over time.What continuing equity exposure does Kamke retain?
Kamke continues to hold 1,353 directly owned stock options, which can be exercised for additional common shares in the future, preserving potential upside alignment with company performance.Company overviewMetricValueRevenue (TTM)$249.6 millionNet income (TTM)$57.7 millionDividend yield0.99%1-year price change32.90%* 1-year price change calculated using March 11, 2026, as the reference date.

Company snapshotOffers a portfolio of medical devices and implants for the treatment of peripheral vascular disease, including angioscopes, embolectomy and thrombectomy catheters, carotid shunts, vascular grafts, and closure systems.Generates revenue primarily through direct sales and distributor relationships, focusing on proprietary vascular products designed for surgical intervention and vascular repair.Serves hospitals, surgeons, and healthcare providers treating vascular disease, with a global customer base spanning North America, Europe, and other international markets.LeMaitre Vascular operates at scale in the medical instruments and supplies industry, leveraging a focused product portfolio to address critical needs in vascular surgery. The company’s strategy centers on innovation in device design and direct engagement with healthcare professionals, supporting consistent revenue growth and profitability. Its competitive position is reinforced by specialized offerings and a global distribution network.

What this transaction means for investorsAs the Senior Vice President of Operations, Kamke likely receives a large portion of his compensation in the form of stock options. With shares of LeMaitre up by more than 30% this year, this transaction looks like an insider supplementing their income. It doesn’t look like the action of an insider trying to exit a doomed investment.

For the fourth quarter of 2025, LeMaitre reported sales that rose 16% year over year to reach $64.5 million. Earnings rose by 39% to $0.68 per share. The outstanding performance supports a big 25% dividend payout bump. The medical device company’s payout has risen by 125% over the past five years. At recent prices, the stock offers a 0.9% dividend yield.

LeMaitre Vascular expects the strong growth it recorded last year to continue. At the midpoint of the guidance range provided by management, sales are expected to rise by 12% this year. On the bottom line, management predicts adjusted earnings will soar 22% higher this year.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool recommends LeMaitre Vascular. The Motley Fool has a disclosure policy.

33.5K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ARLO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.